|
KR102510368B1
(ko)
|
2006-04-14 |
2023-03-14 |
아스텔라스 인스티튜트 포 리제너러티브 메디슨 |
혈관 콜로니 형성 세포
|
|
US8741644B2
(en)
|
2009-09-08 |
2014-06-03 |
Kyoto University |
Method for producing mast cells from pluripotent stem cells
|
|
CA3174901A1
(en)
|
2009-11-12 |
2011-05-19 |
Technion Research & Development Foundation Ltd. |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
|
WO2011068792A2
(en)
*
|
2009-12-01 |
2011-06-09 |
The Regents Of The University Of California |
Compositions and methods for making and using bone marrow mesenchymal stem cells and erythroid progenitor cells
|
|
US8822218B2
(en)
*
|
2009-12-04 |
2014-09-02 |
Stem Cell & Regenerative Medicine International, Inc. |
Method of generating natural killer cells and dendritic cells from human embryonic stem cell-derived hemangioblasts
|
|
US9428735B2
(en)
|
2010-02-25 |
2016-08-30 |
The Johns Hopkins University |
Smooth muscle-like cells (SMLCs) dervided from human pluripotent stem cells
|
|
WO2011159684A2
(en)
|
2010-06-15 |
2011-12-22 |
Cellular Dynamics International, Inc. |
Generation of induced pluripotent stem cells from small volumes of peripheral blood
|
|
US8765470B2
(en)
|
2010-08-04 |
2014-07-01 |
Cellular Dynamics International, Inc. |
Reprogramming immortalized B-cells to induced pluripotent stem cells
|
|
CN102985531B
(zh)
|
2010-09-10 |
2019-04-23 |
国立大学法人东京大学 |
涉及由多能干细胞向血细胞分化的培养方法
|
|
WO2012103098A2
(en)
*
|
2011-01-24 |
2012-08-02 |
Immunepath, Inc. |
Compositions and methods for treating hematological cytopenias
|
|
JP6148429B2
(ja)
*
|
2011-01-31 |
2017-06-14 |
協和発酵バイオ株式会社 |
ヒト多能性幹細胞の培養方法
|
|
JP6005666B2
(ja)
*
|
2011-02-08 |
2016-10-12 |
セルラー ダイナミクス インターナショナル, インコーポレイテッド |
プログラミングによる造血前駆細胞の生産
|
|
CN102161980B
(zh)
*
|
2011-02-12 |
2013-07-31 |
浙江大学 |
用人间充质干细胞为滋养层培养诱导多能干细胞的方法
|
|
US9499789B2
(en)
|
2011-02-23 |
2016-11-22 |
Kyoto University |
Method for producing dendritic cells from pluripotent stem cells
|
|
GB201103600D0
(en)
|
2011-03-01 |
2011-04-13 |
Isis Innovation |
Dendritic cells
|
|
US9169309B2
(en)
*
|
2011-03-01 |
2015-10-27 |
Humanzyme Inc. |
Thermostable variants of fibroblast growth factors
|
|
EP2694644B1
(en)
*
|
2011-03-30 |
2018-01-24 |
Cellular Dynamics International, Inc. |
Priming of pluripotent stem cells for neural differentiation
|
|
WO2012168167A1
(en)
*
|
2011-06-09 |
2012-12-13 |
F. Hoffmann-La Roche Ag |
Method for differentiation of pluripotent stem cells into vascular bed cells
|
|
MX348188B
(es)
*
|
2011-09-29 |
2017-06-01 |
Cellsnap Llc |
Composiciones y metodos para pruebas de toxigenicidad.
|
|
EP2765187B1
(en)
*
|
2011-10-03 |
2018-08-08 |
Nissan Chemical Industries, Ltd. |
Method for producing megakaryocytes and/or platelets from pluripotent stem cells
|
|
CN110241083A
(zh)
*
|
2011-11-21 |
2019-09-17 |
大学健康网络 |
造血祖细胞群体和富集其干细胞的方法
|
|
LT2785359T
(lt)
|
2011-11-30 |
2018-11-12 |
Astellas Institute For Regenerative Medicine |
Mezenchiminės stromos ląstelės ir su jomis susiję naudojimo būdai
|
|
US8961956B2
(en)
|
2011-11-30 |
2015-02-24 |
Ocata Therapeutics, Inc. |
Mesenchymal stromal cells and uses related thereto
|
|
CA2857295C
(en)
*
|
2011-12-01 |
2021-06-29 |
New York Stem Cell Foundation |
Automated system for producing induced pluripotent stem cells or differentiated cells
|
|
US10428309B2
(en)
|
2011-12-01 |
2019-10-01 |
New York Stem Cell Foundation, Inc. |
Systems and methods for producing stem cells and differentiated cells
|
|
EP2820123B1
(en)
*
|
2012-02-29 |
2017-10-11 |
The Johns Hopkins University |
Method for guiding the derivation of endothelial cells from human pluripotent stem cells employing two-dimensional, feeder-free differentiation
|
|
US9260696B2
(en)
|
2012-04-24 |
2016-02-16 |
Dan S. Kaufman |
Method for developing natural killer cells from stem cells
|
|
GB201210857D0
(en)
|
2012-06-19 |
2012-08-01 |
Cambridge Entpr Ltd |
Transcription factor mediated programming towards megakaryocytes
|
|
CA2876499C
(en)
|
2012-07-12 |
2021-10-26 |
Imstem Biotechnology, Inc. |
Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
|
|
US10286014B2
(en)
*
|
2012-09-28 |
2019-05-14 |
Foundation For Biomedical Research And Innovation At Kobe |
Method for in vitro proliferation of cell population containing cells suitable for treatment of ischemic disease
|
|
CA2885294A1
(en)
|
2012-11-21 |
2014-05-30 |
Merz Pharma Gmbh & Co. Kgaa |
Means and methods for determination of botulinum neurotoxin biological activity
|
|
US10426799B2
(en)
|
2012-12-21 |
2019-10-01 |
Astellas Institute For Regenerative Medicine |
Methods for production of platelets from pluripotent stem cells and compositions thereof
|
|
CA2905786C
(en)
|
2013-03-13 |
2022-01-25 |
Wisconsin Alumni Research Foundation |
Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions
|
|
EP2970902B1
(en)
*
|
2013-03-15 |
2019-11-20 |
The Johns Hopkins University |
Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix
|
|
US10731132B2
(en)
|
2013-03-15 |
2020-08-04 |
Amniotics Ab |
Methods and apparatuses for umbilical cord blood collection and isolation of cells
|
|
US9506037B2
(en)
|
2013-03-15 |
2016-11-29 |
The Johns Hopkins University |
Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix
|
|
US9994825B2
(en)
|
2013-03-15 |
2018-06-12 |
The Johns Hopkins University |
Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix
|
|
JP6429280B2
(ja)
*
|
2013-05-14 |
2018-11-28 |
国立大学法人京都大学 |
効率的な心筋細胞の誘導方法
|
|
JP5511039B1
(ja)
*
|
2013-05-22 |
2014-06-04 |
国立大学法人九州大学 |
Nk細胞の調製方法
|
|
WO2014189144A1
(ja)
*
|
2013-05-23 |
2014-11-27 |
国立大学法人京都大学 |
骨髄異形成症候群等の治療/予防薬のスクリーニング方法
|
|
WO2014200340A1
(en)
*
|
2013-06-10 |
2014-12-18 |
Academisch Ziekenhuis Leiden |
Differentiation and expansion of endothelial cells from pluripotent stem cells and the in vitro formation of vasculature like structures
|
|
SG11201510685UA
(en)
|
2013-06-28 |
2016-01-28 |
Merz Pharma Gmbh & Co Kgaa |
Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells
|
|
EP3052615B1
(en)
|
2013-10-01 |
2021-12-29 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Human ipsc-derived vascular-related and hematopoetic cells for therapies and toxicology/drug screenings
|
|
WO2015119642A1
(en)
*
|
2014-02-10 |
2015-08-13 |
The Johns Hopkins University |
Low oxygen tension enhances endothelial fate of human pluripotent stem cells
|
|
HK1226481B
(zh)
|
2014-02-19 |
2017-09-29 |
莫茨药物股份两合公司 |
在体外试验系统中用於使细胞对肉毒神经毒素的敏感性标准化和增加的神经节苷脂
|
|
JP6933898B2
(ja)
|
2014-04-24 |
2021-09-08 |
ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System |
養子細胞治療製品を製造するための誘導多能性幹細胞の適用
|
|
CN103937743B
(zh)
*
|
2014-04-27 |
2017-12-01 |
浙江大学 |
一种利用三维诱导系统获得造血干细胞的方法
|
|
MX382747B
(es)
|
2014-08-04 |
2025-03-11 |
Nuevolution As |
Derivados de pirimidina sustituidos con heterociclilo opcionalmente condensados útiles para el tratamiento de enfermedades inflamatorias, metabólicas oncológicas y autoinmunitarias.
|
|
JP6772138B2
(ja)
|
2014-12-19 |
2020-10-21 |
メルツ ファルマ ゲーエムベーハー ウント コンパニー カーゲーアーアー |
細胞内のBoNT/Eの生物学的活性を決定するための手段及び方法
|
|
US10724003B2
(en)
|
2015-01-16 |
2020-07-28 |
Agency For Science, Technology And Research |
Method of differentiating human pluripotent stem cells into primitive macrophages
|
|
US9828634B2
(en)
|
2015-01-22 |
2017-11-28 |
Regenerative Medical Solutions, Inc. |
Markers for differentiation of stem cells into differentiated cell populations
|
|
AU2016211671B2
(en)
*
|
2015-01-26 |
2022-05-26 |
Fate Therapeutics, Inc. |
Methods and compositions for inducing hematopoietic cell differentiation
|
|
TWI704156B
(zh)
|
2015-03-04 |
2020-09-11 |
德商曼茲法瑪股份有限公司 |
用於增進肉毒桿菌神經毒素進入細胞之特定攝取的方法
|
|
EP3298131B1
(en)
*
|
2015-05-20 |
2023-04-26 |
The Regents of The University of California |
Method for generating human dendritic cells for immunotherapy
|
|
EP4026563B1
(en)
*
|
2015-06-18 |
2025-10-29 |
Yeda Research and Development Co. Ltd |
Conditioning protocols and use of same for tissue regeneration
|
|
JP6884354B2
(ja)
|
2015-09-08 |
2021-06-09 |
大日本住友製薬株式会社 |
網膜組織の製造方法
|
|
JP7061961B2
(ja)
*
|
2015-10-20 |
2022-05-02 |
フジフィルム セルラー ダイナミクス,インコーポレイテッド |
多能性幹細胞の免疫細胞への分化を誘導する方法
|
|
CA3003145C
(en)
|
2015-10-30 |
2025-11-18 |
The Regents Of The University Of California |
METHODS FOR GENERATION OF T LYMPHOCYTES FROM STEM CELLS AND IMMUNOTHERAPY METHODS USING SAID T LYMPHOCYTES
|
|
SG11201803145RA
(en)
|
2015-11-04 |
2018-05-30 |
Fate Therapeutics Inc |
Methods and compositions for inducing hematopoietic cell differentiation
|
|
CN108368520B
(zh)
|
2015-11-04 |
2023-01-17 |
菲特治疗公司 |
多能细胞的基因组工程改造
|
|
CN105296428A
(zh)
*
|
2015-12-03 |
2016-02-03 |
广州医科大学附属第三医院 |
一种提高诱导多能干细胞的体外分化造血效率的方法
|
|
US20190002834A1
(en)
*
|
2015-12-29 |
2019-01-03 |
Kuraray Co., Ltd. |
Method for preparing population of stem cell spheroids
|
|
GB201601503D0
(en)
|
2016-01-27 |
2016-03-09 |
Isis Innovation |
Dendritic cells
|
|
CN111334463B
(zh)
|
2016-05-18 |
2024-02-20 |
学校法人庆应义塾 |
类器官培养用细胞培养基、培养方法及类器官
|
|
WO2018021566A1
(ja)
*
|
2016-07-29 |
2018-02-01 |
ダイキン工業株式会社 |
分化細胞の製造方法、及びその製造方法のために使用する培養バッグ
|
|
JP6963555B2
(ja)
*
|
2016-09-02 |
2021-11-10 |
タカラバイオ株式会社 |
多能性幹細胞からミクログリアを得る方法
|
|
EP3510145A4
(en)
|
2016-09-06 |
2020-03-25 |
The Children's Medical Center Corporation |
IMMUNCELLS FROM INDUCED PLURIPOTENT STEM CELLS
|
|
CN110023491B
(zh)
*
|
2016-10-05 |
2024-03-08 |
富士胶片细胞动力公司 |
多能干细胞定向分化为hla纯合免疫细胞的方法
|
|
US10961505B2
(en)
|
2016-10-05 |
2021-03-30 |
FUJIFILM Cellular Dynamics, Inc. |
Generating mature lineages from induced pluripotent stem cells with MECP2 disruption
|
|
CN106479968A
(zh)
*
|
2016-10-11 |
2017-03-08 |
海南博鳌龄迈迪精准医学研究院有限公司 |
脐带间充质干细胞的培养方法
|
|
WO2018073615A1
(en)
|
2016-10-21 |
2018-04-26 |
Longboat Explorers Ab |
Methods and compositions for generating hematopoietic cells
|
|
CN106754684A
(zh)
*
|
2017-01-05 |
2017-05-31 |
厚朴生物科技(苏州)有限公司 |
一种睾丸间质干细胞分离培养分化方法
|
|
WO2018139600A1
(ja)
|
2017-01-27 |
2018-08-02 |
株式会社カネカ |
内胚葉系細胞集団、及び多能性細胞から三胚葉のいずれかの細胞集団を製造する方法
|
|
CN110520167B
(zh)
*
|
2017-02-03 |
2023-03-24 |
康奈尔大学 |
稳定的三维血管和形成其的方法
|
|
WO2018172420A1
(en)
*
|
2017-03-21 |
2018-09-27 |
Etablissement Francais Du Sang |
Methods of improving hematopoietic grafts
|
|
JP7181219B2
(ja)
|
2017-04-18 |
2022-11-30 |
フジフィルム セルラー ダイナミクス,インコーポレイテッド |
抗原特異的免疫エフェクター細胞
|
|
EP3399027A1
(en)
|
2017-05-04 |
2018-11-07 |
Medizinische Hochschule Hannover |
Stem-cell derived myeloid cells, generation and use thereof
|
|
CN107083367B
(zh)
*
|
2017-07-03 |
2020-07-14 |
广州润虹医药科技股份有限公司 |
培养基及其用途与由尿液细胞制备间充质干细胞的方法
|
|
CN110770335A
(zh)
*
|
2017-12-11 |
2020-02-07 |
韩国疾病预防控制中心 |
使用多能干细胞的免疫细胞的分化
|
|
US11365390B2
(en)
|
2017-12-19 |
2022-06-21 |
Xcell Biosciences, Inc. |
Methods of modulating cell phenotype by way of regulating the gaseous environment
|
|
CN108048390B
(zh)
*
|
2017-12-21 |
2021-04-27 |
清华大学 |
一种制备血管内皮细胞的方法及其专用试剂盒
|
|
CN108588024B
(zh)
*
|
2017-12-29 |
2020-04-21 |
广州医科大学附属第三医院(广州重症孕产妇救治中心、广州柔济医院) |
诱导多能干细胞分化成造血干细胞的培养基及方法
|
|
CN111836886A
(zh)
*
|
2018-01-05 |
2020-10-27 |
血小板生源说股份有限公司 |
用于产生巨核细胞的组合物和方法
|
|
SG11202007221QA
(en)
|
2018-02-01 |
2020-08-28 |
Nkmax Co Ltd |
Method of producing natural killer cells and composition for treating cancer
|
|
FR3079239A1
(fr)
*
|
2018-03-23 |
2019-09-27 |
Centre National De La Recherche Scientifique |
Nouvelle methode d’obtention de cellules t a partir de cellules souches pluripotentes, et leurs utilisations
|
|
US12403161B2
(en)
|
2018-06-29 |
2025-09-02 |
Stellular Bio, Inc. |
Compositions for drug delivery and methods of use thereof
|
|
KR20210061397A
(ko)
|
2018-09-19 |
2021-05-27 |
후지필름 셀룰러 다이내믹스, 인코포레이티드 |
키메라 항원 수용체-변형된 면역 세포의 활성화 및 확장을 위한 단백질 l
|
|
CN109266618B
(zh)
*
|
2018-10-18 |
2021-04-23 |
赛元生物科技(杭州)有限公司 |
能够靶向肿瘤细胞的巨噬细胞及其制备方法
|
|
BR112021007748A2
(pt)
*
|
2018-10-24 |
2021-07-27 |
Hebecell Corporation |
métodos e sistemas para fabricar células de linhagem hematopoiética
|
|
KR102111441B1
(ko)
*
|
2018-11-12 |
2020-05-15 |
대한민국 |
전분화능 줄기세포 유래 대식세포를 기반으로 하는 감염질환 치료용 약물 스크리닝 방법
|
|
TWI843782B
(zh)
*
|
2018-12-20 |
2024-06-01 |
日商住友化學股份有限公司 |
含有胚胎型紅血球母細胞的細胞集團的製造方法及化合物試驗法
|
|
JP7634938B2
(ja)
*
|
2019-02-21 |
2025-02-25 |
ピービーエス バイオテック インコーポレイテッド |
バイオリアクターにおける治療細胞の膨張および分化のためのシステムおよび方法
|
|
CN111206017B
(zh)
*
|
2019-04-30 |
2022-02-18 |
浙江大学 |
一种干细胞无血清培养基及其应用
|
|
KR20220032561A
(ko)
*
|
2019-06-14 |
2022-03-15 |
후지필름 셀룰러 다이내믹스, 인코포레이티드 |
하전된 표면을 사용하여 유도 만능 줄기 세포로부터 다중 계통을 생산하는 방법
|
|
WO2020256628A1
(en)
|
2019-06-20 |
2020-12-24 |
Amniotics Ab |
An apparatus for filtering amniotic fluid
|
|
EP4045068A1
(en)
|
2019-10-18 |
2022-08-24 |
Amniotics AB |
Use of term amniotic fluid cells for the treatment of acute and chronic respiratory diseases
|
|
JP7479466B2
(ja)
|
2019-11-13 |
2024-05-08 |
カリス バイオ インコーポレイテッド |
血管内皮細胞純粋分離方法、血管内皮細胞特性維持培地及びそれを含む培養方法
|
|
CN110938584B
(zh)
*
|
2019-11-25 |
2021-12-03 |
广州赛莱拉干细胞科技股份有限公司 |
一种人胚胎干细胞向内皮细胞诱导分化的方法
|
|
CA3160522A1
(en)
|
2019-12-20 |
2021-06-24 |
Sanne Schroder Glad |
Compounds active towards nuclear receptors
|
|
UY38994A
(es)
|
2019-12-20 |
2021-07-30 |
Nuevolution As |
Compuestos activos frente a receptores nucleares
|
|
CN115135754A
(zh)
*
|
2020-02-28 |
2022-09-30 |
普渡研究基金会 |
在限定条件下从人多能干细胞生成主动脉-性腺-中肾样造血细胞
|
|
US12220445B2
(en)
|
2020-03-09 |
2025-02-11 |
Amprion, Inc. |
Inert matrices for qualitative and semi-quantitative seed amplification assays
|
|
CN111440760B
(zh)
*
|
2020-03-09 |
2022-09-23 |
浙江大学 |
一种人多能干细胞高效分化得到内皮祖细胞的方法
|
|
US11547726B2
(en)
|
2020-03-26 |
2023-01-10 |
Honed Life Sciences, Llc |
Enhancement of production of NK cells from stem cells
|
|
CA3174176A1
(en)
|
2020-03-31 |
2021-10-07 |
Sanne Schroder Glad |
Compounds active towards nuclear receptors
|
|
AU2021245397A1
(en)
|
2020-03-31 |
2022-10-20 |
Nuevolution A/S |
Compounds active towards nuclear receptors
|
|
US20230257705A1
(en)
|
2020-06-17 |
2023-08-17 |
Kyoto University |
Chimeric antigen receptor-expressing immunocompetent cells
|
|
EP4189068A4
(en)
*
|
2020-07-27 |
2024-08-28 |
Stemcell Technologies Canada Inc. |
SYSTEMS AND METHODS FOR DIFFERENTIATION OF HEMATOPOETIC CELLS
|
|
CN111808812B
(zh)
*
|
2020-08-31 |
2020-12-15 |
首都医科大学附属北京友谊医院 |
一种用于多能干细胞向造血干细胞分化的材料和方法
|
|
US12435308B2
(en)
|
2020-11-06 |
2025-10-07 |
Amniotics Ab |
Immunomodulation by amniotic fluid mesenchymal stem cells
|
|
EP4251741A1
(en)
|
2020-11-30 |
2023-10-04 |
CRISPR Therapeutics AG |
Gene-edited natural killer cells
|
|
KR20230118887A
(ko)
|
2020-12-03 |
2023-08-14 |
센츄리 쎄라퓨틱스 인코포레이티드 |
유전자 조작 세포 및 이의 용도
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
CN112608895B
(zh)
*
|
2020-12-18 |
2024-02-27 |
深圳市济因生物科技有限公司 |
一种人多能干细胞分化的自然杀伤细胞及其制备方法与应用
|
|
US11473060B2
(en)
|
2020-12-30 |
2022-10-18 |
Crispr Therapeutics Ag |
Compositions and methods for differentiating stem cells into NK cells
|
|
EP4320224A1
(en)
|
2021-04-07 |
2024-02-14 |
Century Therapeutics, Inc. |
Compositions and methods for generating alpha-beta t cells from induced pluripotent stem cells
|
|
WO2022216514A1
(en)
|
2021-04-07 |
2022-10-13 |
Century Therapeutics, Inc. |
Compositions and methods for generating gamma-delta t cells from induced pluripotent stem cells
|
|
JP2024513454A
(ja)
|
2021-04-07 |
2024-03-25 |
センチュリー セラピューティクス,インコーポレイテッド |
キメラ抗原受容体細胞のための人工細胞死/リポーター系ポリペプチドの組合せおよびその使用
|
|
AU2022253891A1
(en)
|
2021-04-07 |
2023-08-24 |
Century Therapeutics, Inc. |
Gene transfer vectors and methods of engineering cells
|
|
US20240191186A1
(en)
|
2021-05-05 |
2024-06-13 |
FUJIFILM Cellular Dynamics, Inc. |
Methods and compositions for ipsc-derived microglia
|
|
CA3231278A1
(en)
|
2021-09-10 |
2023-03-16 |
Deepika Rajesh |
Compositions of induced pluripotent stem cell-derived cells and methods of use thereof
|
|
KR20240067087A
(ko)
*
|
2021-09-13 |
2024-05-16 |
암프리온, 인코퍼레이티드 |
정성적 및 반정량적 시드 증폭 검정을 위한 불활성 매트릭스
|
|
WO2023110045A1
(en)
|
2021-12-15 |
2023-06-22 |
Y-Mabs Therapeutics, Inc. |
Scfv and antibodies with reduced multimerisation
|
|
WO2023129937A1
(en)
|
2021-12-29 |
2023-07-06 |
Century Therapeutics, Inc. |
Genetically engineered cells having anti-cd19 / anti-cd22 chimeric antigen receptors, and uses thereof
|
|
WO2023164440A1
(en)
|
2022-02-22 |
2023-08-31 |
Juno Therapeutics, Inc. |
Proteinase 3 (pr3) chimeric autoantibody receptor t cells and related methods and uses
|
|
US20250345425A1
(en)
|
2022-05-04 |
2025-11-13 |
Century Therapeutics, Inc. |
Cells engineered with an hla-e and hla-g transgene
|
|
JP2025522360A
(ja)
|
2022-06-08 |
2025-07-15 |
センチュリー セラピューティクス,インコーポレイテッド |
Cd16変異体およびnkg2dを発現する遺伝子操作した細胞ならびにその使用
|
|
US20250090582A1
(en)
|
2022-06-08 |
2025-03-20 |
Century Therapeutics, Inc. |
Genetically engineered cells having anti-cd133 / anti-egfr chimeric antigen receptors, and uses thereof
|
|
WO2023240169A1
(en)
|
2022-06-08 |
2023-12-14 |
Century Therapeutics, Inc. |
Immunoeffector cells derived from induced pluripotent stem cells genetically engineered with membrane bound il12 and uses thereof
|
|
WO2024102838A1
(en)
|
2022-11-09 |
2024-05-16 |
Century Therapeutics, Inc. |
Engineered interleukin-7 receptors and uses thereof
|
|
WO2024103017A2
(en)
|
2022-11-10 |
2024-05-16 |
Century Therapeutics, Inc. |
Genetically engineered cells having anti-nectin4 chimeric antigen receptors, and uses thereof
|
|
US20240269189A1
(en)
|
2022-12-19 |
2024-08-15 |
FUJIFILM Holdings America Corporation |
Extracellular vesicle-enriched secretome composition derived from induced pluripotent stem cell derived-microglia and methods of use thereof
|
|
EP4665846A2
(en)
*
|
2023-02-16 |
2025-12-24 |
Syntax Bio, Inc. |
Systems for cell programming towards hematopoietic lineage and methods thereof
|
|
CN116426472A
(zh)
*
|
2023-06-08 |
2023-07-14 |
呈诺再生医学科技(北京)有限公司 |
一种促进造血干细胞或造血祖细胞分化为红细胞的诱导分化体系及其应用
|
|
WO2025101938A2
(en)
|
2023-11-10 |
2025-05-15 |
Century Therapeutics, Inc. |
Genetically engineered cells having multi-transmembrane domain chimeric antigen receptors utilizing g protein-coupled receptor scaffolds, and uses thereof
|
|
WO2025106626A1
(en)
|
2023-11-15 |
2025-05-22 |
Century Therapeutics, Inc. |
Genetically engineered cells expressing c-x-c chemokine receptor type 4, and uses thereof
|
|
WO2025207795A1
(en)
|
2024-03-26 |
2025-10-02 |
Juno Therapeutics, Inc. |
Genetically engineered cells having anti-cd33 / anti-cd123 chimeric antigen receptors, and uses thereof
|
|
WO2025207798A1
(en)
|
2024-03-26 |
2025-10-02 |
Century Therapeutics, Inc. |
Genetically engineered cells having anti-cd123 chimeric antigen receptors, and uses thereof
|